AdvaMed: N.J. will be hit hard by device tax; Epistem looks to cash in on TB diagnostic;

@FierceMedDev: The FDA is finally moving forward with its device ID plan, but will it actually help keep patients safe? Item | Follow @FierceMedDev

 @MarkHFierce: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @MarkHFierce

 @DamianFierce: MDxHealth has signed a deal with Merck KGaA to provide companion diagnostics for a pipeline cancer drug. Story | Follow @DamianFierce

> In an editorial, AdvaMed CEO Stephen Ubl says, unless it's repealed, the 2.3% device tax will particularly harm New Jersey, hampering small devicemakers' ability to survive and stamping out startups before they have a chance to turn profits. More

> With CE mark in hand, diagnostics firm Epistem is likely to lock down more partnerships for Genedrive, its rapid tuburculosis test. Item

> Scientists are working on a closed-loop implantable device to treat seizures, detecting brain patterns and delivering drugs as needed without external controls. News

> U.K. devicemaker Owen Mumford is investing about $11 million to build a new injector plant in Oxfordshire. Article

> Canadian researchers have discovered that a device designed to improve blood flow in the legs could help prevent thousands of diabetes-related amputations per year. Story

> Startup Harmonic Cold Plasma has secured $1 million to develop its hand-held wound-healing device. Report

Pharma News

@FiercePharma: Spanish drugmakers can't grow at home, so they're looking for international expansion--Bloomberg. More | Follow @FiercePharma

> Sanofi mulls up to 2,000 job cuts in France, unions say. News

> Sanofi chief among then-GSK execs named in DoJ off-label case. Article

> India's anti-brand stance threatens Big Pharma growth. More

> Italy sharpens up for another €1B in health cuts. Story

Biotech News

 @FierceBiotech: Nanofactories can synthesize drugs within the body. More | Follow @FierceBiotech

@JohnCFierce: Roche move spotlights NJ's shrinking role in biopharma R&D. Article | Follow @JohnCFierce

 @RyanMFierce: Software could provide a new measuring tool for Parkinson's during clinical trials. Story | Follow @RyanMFierce

> Sanofi sharpens R&D budget ax as it prepares to cut up to 2,000 jobs. News

> Dr. Reddy's maps out ambitious global plans for biosimilars. Article

> CEO at troubled Cardiome exits in midst of reorganization. Story

Vaccines News

> In $69M IPO bid, GlobeImmune spotlights therapeutic vaccines. Story

> Group tackles dengue vaccine pricing. More

> Soligenix, Infectious Disease Research Institute partner to combat anthrax. Article

> FDA gives Argos green light for kidney cancer immunotherapy. News

Pharma Manufacturing News

 @EricPFierce: China tainted drug capsule scandal leads to new responsibilities for drugmakers. Report | Follow @EricPFierce

> FDA gets device, but not drug tracking .More

> Budget chainsaw may miss Sanofi manufacturing. News

> Glaxo manufacturing must meet special dictates. Story

CRO News

 @NesaNFierce: Argentina is becoming more than the birthplace of Tango, growing in terms of outsourcing. More | Follow @NesaNFierce

> Pernix Therapeutics offers $4.9M for CMO Great Southern Laboratories. Story

> ScinoPharm to build $37M Taiwan plant for cancer injectables. Article

> CMO execs reflect on changing manufacturing front. More

Drug Delivery News

> UPenn turns plant protein into drug-delivery tech. Item

> pSivida eyes FDA approval with trial for Durasert-delivered drug. Story

> InVivo looks to get gel-delivered pain drug on U.S. market. Article

> Northwestern docs deliver siRNA with lotion to stymie cancer. More

> Researchers develop gel to deliver male contraceptive. Story